$HRTX SEC Filings

Filed On	Filing
21 Oct 2026	Form 4: Duarte Ira, EVP, Chief Financial Officer Received 3,874 shares by exercise or conversion · Gave up 1,102 shares to cover exercise price or tax ($397)
21 Oct 2026	Form 4: Forbes William P, EVP, Chief Development Officer Received 3,874 shares by exercise or conversion · Gave up 1,102 shares to cover exercise price or tax ($397)
21 Oct 2026	Form 4: Collard Craig A, Director Received 13,797 shares by exercise or conversion · Gave up 3,360 shares to cover exercise price or tax ($1.21K)
29 Sep 2026	8-K: Entry into a Material Definitive Agreement On September 23, 2026 (the “Effective Date”), Heron Therapeutics, Inc., a Delaware corporation (the “Company”), entered into a multi-product Development and License Agreement (the “License Agreement”) with Long Grove Pharmaceuticals, LLC...
14 Aug 2026	8-K: Entry into a Material Definitive Agreement; Material Modification to Rights of Security Holders
10 Aug 2026	Form 4: Hensley Mark Earl, Chief Operating Officer Received 31,250 shares by exercise or conversion · Gave up 8,888 shares to cover exercise price or tax ($4.44K)
10 Aug 2026	10-Q
10 Aug 2026	8-K: Results of Operations and Financial Condition
03 Aug 2026	Form 4: Hensley Mark Earl, Chief Operating Officer Received 11,769 shares by exercise or conversion
03 Aug 2026	Form 4: Forbes William P, EVP, Chief Development Officer Received 11,769 shares by exercise or conversion · Gave up 3,348 shares to cover exercise price or tax ($1.67K) · Received 11,694 shares by exercise or conversion · 1 more
03 Aug 2026	Form 4: Duarte Ira, EVP, Chief Financial Officer Received 13,535 shares by exercise or conversion · Gave up 3,850 shares to cover exercise price or tax ($1.93K) · Received 11,694 shares by exercise or conversion · 1 more
03 Aug 2026	Form 4: Collard Craig A, Director Received 50,021 shares by exercise or conversion · Received 34,789 shares by exercise or conversion
20 Jul 2026	Form 4: Collard Craig A, Director Received 13,797 shares by exercise or conversion
20 Jul 2026	Form 4: Forbes William P, EVP, Chief Development Officer Received 3,874 shares by exercise or conversion · Gave up 1,101 shares to cover exercise price or tax ($517)
20 Jul 2026	Form 4: Duarte Ira, EVP, Chief Financial Officer Received 3,874 shares by exercise or conversion · Gave up 1,101 shares to cover exercise price or tax ($517)
25 Jun 2026	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
17 Jun 2026	Form 4: Duarte Ira, EVP, Chief Financial Officer Received 12,500 shares by exercise or conversion · Gave up 3,555 shares to cover exercise price or tax ($1.35K)
16 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
08 Jun 2026	Form 4: Forbes William P, EVP, Chief Development Officer Received 12,500 shares by exercise or conversion
02 Jun 2026	8-K: Other Events

Comments